Alloimmune conditions and pregnancy.

Area of Science:

• Perinatal immunology
• Maternal-fetal medicine
• Transfusion medicine

Background:

• Fetal cells in maternal circulation can trigger immune responses, leading to fetal complications like anemia and hydrops.
• Maternal sensitization to red blood cell antigens (e.g., D, Kell) poses risks to incompatible fetuses.
• Passage of maternal stem cells to fetuses can theoretically cause graft-versus-host disease.

Purpose of the Study:

• To review current methods for assessing and managing immune-mediated fetal complications.
• To highlight the role of diagnostic procedures and transfusion therapies in high-risk pregnancies.
• To discuss the management of isoimmune fetal thrombocytopenia and associated risks.

Main Methods:

• Review of existing literature on maternal sensitization and fetal complications.
• Discussion of diagnostic techniques including amniotic fluid analysis and umbilical cord blood sampling.
• Evaluation of treatment strategies such as intravascular and intraperitoneal transfusion.

Main Results:

• Current diagnostic methods like ultrasound and Doppler are inaccurate for predicting fetal hematocrit.
• Intravascular transfusion is the preferred treatment for hydropic fetuses.
• Umbilical cord blood sampling at term is vital for managing fetal thrombocytopenia and preventing intracranial hemorrhage.

Conclusions:

• Effective management of immune-mediated fetal complications requires accurate diagnostics and timely interventions.
• Umbilical cord blood sampling plays a critical role in managing fetal thrombocytopenia and guiding delivery decisions.
• Individualized treatment approaches are necessary for optimal perinatal outcomes in high-risk pregnancies.